Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Adenosine-phosphate | hsa00010 | Glycolysis / Gluconeogenesis | 4.41E-02 | 4 | P04075, P06733, P04406, P60174 | ALDOA, ENO1, GAPDH, TPI1 | More | | Adenosine-phosphate | hsa00030 | Pentose phosphate pathway | 1.09E-06 | 5 | P60891, P51854, P08237, P52209, P37837 | PRPS1, TKTL1, PFKM, PGD, TALDO1 | More | | Adenosine-phosphate | hsa00051 | Fructose and mannose metabolism | 2.21E-02 | 3 | O14772, P60174, P04075 | FPGT, TPI1, ALDOA | More | | Adenosine-phosphate | hsa00052 | Galactose metabolism | 6.10E-03 | 3 | P06280, O43451, P35557 | GLA, MGAM, GCK | More | | Adenosine-phosphate | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Adenosine-phosphate | hsa00061 | Fatty acid biosynthesis | 1.52E-03 | 1 | Q9UKU0 | ACSL6 | More | | Adenosine-phosphate | hsa00071 | Fatty acid degradation | 4.55E-03 | 1 | Q9UKU0 | ACSL6 | More | | Adenosine-phosphate | hsa00100 | Steroid biosynthesis | 1.84E-03 | 1 | P35610 | SOAT1 | More | | Adenosine-phosphate | hsa00190 | Oxidative phosphorylation | 4.56E-03 | 7 | O95298, Q16718, O15239, P12074, P36542, P05496, O14521 | NDUFC2, NDUFA5, NDUFA1, COX6A1, ATP5C1, ATP5G1, SDHD | More | | Adenosine-phosphate | hsa00220 | Arginine biosynthesis | 1.84E-05 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Adenosine-phosphate | hsa00230 | Purine metabolism | 2.11E-02 | 3 | Q7LG56, P31350, P21589 | RRM2B, RRM2, NT5E | More | | Adenosine-phosphate | hsa00240 | Pyrimidine metabolism | 6.02E-09 | 6 | Q7LG56, P31350, P21589, P32320, P04183, P04818 | RRM2B, RRM2, NT5E, CDA, TK1, TYMS | More | | Adenosine-phosphate | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.40E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Adenosine-phosphate | hsa00280 | Valine, leucine and isoleucine degradation | 3.30E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Adenosine-phosphate | hsa00310 | Lysine degradation | 3.73E-03 | 3 | Q96KQ7, Q02809, P51648 | EHMT2, PLOD1, ALDH3A2 | More | | Adenosine-phosphate | hsa00410 | beta-Alanine metabolism | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Adenosine-phosphate | hsa00440 | Phosphonate and phosphinate metabolism | 3.98E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Adenosine-phosphate | hsa00471 | D-Glutamine and D-glutamate metabolism | 1.54E-03 | 2 | Q7Z3D6, P49448 | C14orf159, GLUD2 | More | | Adenosine-phosphate | hsa00480 | Glutathione metabolism | 3.85E-02 | 2 | Q7LG56, P31350 | RRM2B, RRM2 | More | | Adenosine-phosphate | hsa00500 | Starch and sucrose metabolism | 2.31E-07 | 4 | O43451, P46976, P35557, P06737 | MGAM, GYG1, GCK, PYGL | More | | Adenosine-phosphate | hsa00512 | Mucin type O-glycan biosynthesis | 1.22E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Adenosine-phosphate | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 8.73E-04 | 1 | P35557 | GCK | More | | Adenosine-phosphate | hsa00562 | Inositol phosphate metabolism | 4.55E-02 | 2 | P27987, P42338 | ITPKB, PIK3CB | More | | Adenosine-phosphate | hsa00564 | Glycerophospholipid metabolism | 2.07E-03 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Adenosine-phosphate | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Adenosine-phosphate | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Adenosine-phosphate | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.57E-05 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Adenosine-phosphate | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Adenosine-phosphate | hsa00740 | Riboflavin metabolism | 3.98E-02 | 1 | Q969G6 | RFK | More | | Adenosine-phosphate | hsa00770 | Pantothenate and CoA biosynthesis | 7.20E-04 | 3 | O95498, Q6ZQY3, Q9NRN7 | VNN2, GADL1, AASDHPPT | More | | Adenosine-phosphate | hsa00910 | Nitrogen metabolism | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Adenosine-phosphate | hsa00983 | Drug metabolism - other enzymes | 2.03E-08 | 6 | P04183, P20839, P32320, Q7LG56, P31350, P05164 | TK1, IMPDH1, CDA, RRM2B, RRM2, MPO | More | | Adenosine-phosphate | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Adenosine-phosphate | hsa01100 | Metabolic pathways | 1.28E-04 | 55 | Q9NR34, Q9Y234, P35790, P05089, P21953, Q16772, P15144, P30041, P15104, P42338, O14732, P27987, P32320, Q02153, Q16774, P20839, P00918, P22748, P10768, P55809, P06280, Q16875, O43286, O43451, P53004, Q9Y6K0, P05186, P24666, P08237, P21399, Q9HCC0, P33121, Q9UHK6, P51854, Q86VZ5, P09917, Q9BVK2, P15907, P57054, Q9UNP4, O96024, Q9BX95, P37837, P32321, P49448, P50213, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q969G6, Q13029, Q9NVH6 | MAN1C1, LIPT1, CHKA, ARG1, BCKDHB, GSTA3, ANPEP, PRDX6, GLUL, PIK3CB, IMPA2, ITPKB, CDA, GUCY1B3, GUK1, IMPDH1, CA2, CA4, ESD, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, BLVRA, CEPT1, ALPL, ACP1, PFKM, ACO1, MCCC2, ACSL1, AMACR, TKTL1, SGMS1, ALOX5, ALG8, ST6GAL1, PIGP, ST3GAL5, B3GALT4, SGPP1, TALDO1, DCTD, GLUD2, IDH3A, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, RFK, PRDM2, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.778 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P35790 | CHKA | Choline kinase alpha | -0.856 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 0.765 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.768 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15144 | ANPEP | Aminopeptidase N | 0.846 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.785 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P15104 | GLUL | Glutamine synthetase | -0.819 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O14732 | IMPA2 | Inositol monophosphatase 2 | 0.738 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.745 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.774 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16774 | GUK1 | Guanylate kinase | 0.757 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P00918 | CA2 | Carbonic anhydrase 2 | 0.772 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P10768 | ESD | S-formylglutathione hydrolase | -0.701 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.744 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P06280 | GLA | Alpha-galactosidase A | 0.728 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P53004 | BLVRA | Biliverdin reductase A | 0.901 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.771 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.868 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P21399 | ACO1 | Cytoplasmic aconitate hydratase | -0.739 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.784 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P51854 | TKTL1 | Transketolase-like protein 1 | -0.753 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.81 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.705 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.726 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.827 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O96024 | B3GALT4 | Beta-1,3-galactosyltransferase 4 | 0.797 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P37837 | TALDO1 | Transaldolase | 0.732 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P32321 | DCTD | Deoxycytidylate deaminase | 0.79 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | 0.74 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P50213 | IDH3A | Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | -0.732 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | -0.798 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.702 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P46976 | GYG1 | Glycogenin-1 | -0.82 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q969G6 | RFK | Riboflavin kinase | 0.705 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q13029 | PRDM2 | PR domain zinc finger protein 2 | 0.744 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.721 |
| Adenosine-phosphate | hsa01200 | Carbon metabolism | 3.30E-04 | 13 | P04075, P51854, P04406, P08237, P60174, P37837, P06733, O14521, Q9P2R7, P50213, P21399, P10768, Q02252 | ALDOA, TKTL1, GAPDH, PFKM, TPI1, TALDO1, ENO1, SDHD, SUCLA2, IDH3A, ACO1, ESD, ALDH6A1 | More | | Adenosine-phosphate | hsa01210 | 2-Oxocarboxylic acid metabolism | 6.11E-04 | 2 | P21399, P50213 | ACO1, IDH3A | More | | Adenosine-phosphate | hsa01212 | Fatty acid metabolism | 7.59E-03 | 1 | Q9UKU0 | ACSL6 | More | | Adenosine-phosphate | hsa01230 | Biosynthesis of amino acids | 2.08E-04 | 10 | P60174, P04406, P06733, P04075, P08237, P51854, Q99707, P21399, P50213, P37837 | TPI1, GAPDH, ENO1, ALDOA, PFKM, TKTL1, MTR, ACO1, IDH3A, TALDO1 | More | | Adenosine-phosphate | hsa01522 | Endocrine resistance | 3.10E-03 | 5 | P22694, Q9UM47, P04637, P42773, P46527 | PRKACB, NOTCH3, TP53, CDKN2C, CDKN1B | More | | Adenosine-phosphate | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Adenosine-phosphate | hsa01524 | Platinum drug resistance | 4.94E-02 | 2 | P78417, P52701 | GSTO1, MSH6 | More | | Adenosine-phosphate | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Adenosine-phosphate | hsa03008 | Ribosome biogenesis in eukaryotes | 8.16E-03 | 3 | Q9NYH9, P78345, Q9GZY0 | UTP6, RPP38, NXF2; NXF2B | More | | Adenosine-phosphate | hsa03010 | Ribosome | 8.03E-04 | 8 | P62753, P62829, P46777, P62888, P61927, P61513, P36578, P50914 | RPS6, RPL23, RPL5, RPL30, RPL37, RPL37A, RPL4, RPL14 | More | | Adenosine-phosphate | hsa03013 | RNA transport | 4.45E-05 | 16 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, P78345, Q14240, Q9BZI7, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, RPP38, EIF4A2, UPF3B, TACC3, FMR1, FXR1 | More | | Adenosine-phosphate | hsa03015 | mRNA surveillance pathway | 3.37E-02 | 3 | O43148, Q9GZY0, P52298 | RNMT, NXF2; NXF2B, NCBP2 | More | | Adenosine-phosphate | hsa03020 | RNA polymerase | 2.70E-05 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Adenosine-phosphate | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Adenosine-phosphate | hsa03040 | Spliceosome | 4.80E-08 | 17 | Q14562, O43143, O60508, P17844, P08579, P26368, P51991, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, U2AF2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.732 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.789 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.752 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.824 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.701 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.772 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.872 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 |
| Adenosine-phosphate | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Adenosine-phosphate | hsa03060 | Protein export | 2.83E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Adenosine-phosphate | hsa03320 | PPAR signaling pathway | 9.10E-03 | 1 | Q9UKU0 | ACSL6 | More | | Adenosine-phosphate | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Adenosine-phosphate | hsa04015 | Rap1 signaling pathway | 9.14E-03 | 2 | P06213, O00522 | INSR, KRIT1 | More | | Adenosine-phosphate | hsa04020 | Calcium signaling pathway | 2.80E-05 | 12 | P27987, Q96DU7, Q08828, P21796, P45880, Q13557, P21860, P30679, P19174, P0DP23, P05141, P23634 | ITPKB, ITPKC, ADCY1, VDAC1, VDAC2, CAMK2D, ERBB3, GNA15, PLCG1, CALM1, SLC25A5, ATP2B4 | More | | Adenosine-phosphate | hsa04022 | cGMP-PKG signaling pathway | 2.26E-03 | 8 | Q14814, Q99941, P18848, P05141, P21796, P45880, P0DP23, P01042 | MEF2D, CREBL1, ATF4, SLC25A5, VDAC1, VDAC2, CALM1, KNG1 | More | | Adenosine-phosphate | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.90E-02 | 1 | Q99731 | CCL19 | More | | Adenosine-phosphate | hsa04062 | Chemokine signaling pathway | 2.94E-02 | 4 | P07948, P42338, P50151, P49407 | LYN, PIK3CB, GNG10, ARRB1 | More | | Adenosine-phosphate | hsa04064 | NF-kappa B signaling pathway | 3.70E-08 | 17 | P10415, P51617, O00463, P14778, P01584, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q9NQC7 | BCL2, IRAK1, TRAF5, IL1R1, IL1B, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04183 | TK1 | Thymidine kinase, cytosolic | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.763 | P04183 | TK1 | Thymidine kinase, cytosolic | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.756 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.735 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q08828 | ADCY1 | Adenylate cyclase type 1 | P01584 | IL1B | Interleukin-1 beta | 0.75 | P51828 | ADCY7 | Adenylate cyclase type 7 | P01584 | IL1B | Interleukin-1 beta | 0.815 | P04183 | TK1 | Thymidine kinase, cytosolic | Q04759 | PRKCQ | Protein kinase C theta type | -0.729 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.738 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.742 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | Q08828 | ADCY1 | Adenylate cyclase type 1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.75 | P51828 | ADCY7 | Adenylate cyclase type 7 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.72 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.758 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | Q08828 | ADCY1 | Adenylate cyclase type 1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.709 | P51828 | ADCY7 | Adenylate cyclase type 7 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.741 | Q08828 | ADCY1 | Adenylate cyclase type 1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.709 | P51828 | ADCY7 | Adenylate cyclase type 7 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.741 | P04183 | TK1 | Thymidine kinase, cytosolic | P09341 | CXCL1 | Growth-regulated alpha protein | 0.722 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P09341 | CXCL1 | Growth-regulated alpha protein | 0.78 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P51828 | ADCY7 | Adenylate cyclase type 7 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.798 |
| Adenosine-phosphate | hsa04070 | Phosphatidylinositol signaling system | 1.16E-03 | 7 | P19174, P0DP23, O14986, P23743, Q86XP1, P27987, Q96DU7 | PLCG1, CALM1, PIP5K1B, DGKA, DGKH, ITPKB, ITPKC | More | | Adenosine-phosphate | hsa04071 | Sphingolipid signaling pathway | 1.13E-05 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Adenosine-phosphate | hsa04080 | Neuroactive ligand-receptor interaction | 1.07E-03 | 9 | P08311, P00734, Q15722, P21453, Q9H228, Q96G91, P21462, P21730, P07550 | CTSG, F2, LTB4R, S1PR1, EDG8, P2RY11, FPR1, C5AR1, ADRB2 | More | | Adenosine-phosphate | hsa04110 | Cell cycle | 2.76E-05 | 9 | P30260, P06493, O60566, P04637, P49918, P30304, P33981, P42773, P01106 | CDC27, CDK1, BUB1B, TP53, CDKN1C, CDC25A, TTK, CDKN2C, MYC | More | | Adenosine-phosphate | hsa04115 | p53 signaling pathway | 1.37E-05 | 8 | P24522, Q13315, Q7LG56, P31350, Q9HA38, P04637, O95067, P10415 | GADD45A, ATM, RRM2B, RRM2, ZMAT3, TP53, CCNB2, BCL2 | More | | Adenosine-phosphate | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Adenosine-phosphate | hsa04141 | Protein processing in endoplasmic reticulum | 7.24E-05 | 9 | P18848, P30101, Q15437, Q15436, Q99941, P11142, P07900, P08238, Q9NR31 | ATF4, PDIA3, SEC23B, SEC23A, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A | More | | Adenosine-phosphate | hsa04142 | Lysosome | 5.39E-05 | 9 | P22304, P38571, Q13510, Q9UJJ9, P07602, P49279, P61916, Q04900, Q9Y227 | IDS, LIPA, ASAH1, GNPTG, PSAP, SLC11A1, NPC2, CD164, ENTPD4 | More | | Adenosine-phosphate | hsa04144 | Endocytosis | 1.09E-03 | 12 | Q13191, P0DMV8, P11142, Q9H444, P62491, P25024, P43250, Q8WU79, Q14161, P14784, Q9UMY4, Q9Y5X3 | CBLB, HSPA1A, HSPA8, CHMP4B, RAB11A, CXCR1, GRK6, SMAP1L, GIT2, IL2RB, SNX12, SNX5 | More | | Adenosine-phosphate | hsa04145 | Phagosome | 1.73E-04 | 7 | O75015, Q15080, P68371, P05164, P78380, P35443, P13765 | FCGR3B, NCF4, TUBB2C, MPO, OLR1, THBS4, HLA-DOB | More | | Adenosine-phosphate | hsa04146 | Peroxisome | 9.47E-04 | 7 | O43933, O96011, P56589, Q9UKG9, O75521, P33121, Q9UKU0 | PEX1, PEX11B, PEX3, CROT, ECI2, ACSL1, ACSL6 | More | | Adenosine-phosphate | hsa04151 | PI3K-Akt signaling pathway | 4.39E-05 | 16 | P62753, P04637, P27348, P07900, P08238, P62873, P63218, Q16363, P22105, P14784, Q99941, P18848, Q96BR1, O00141, P30279, P56279 | RPS6, TP53, YWHAQ, HSP90AA1, HSP90AB1, GNB1, GNG5, LAMA4, TNXB, IL2RB, CREBL1, ATF4, SGK3, SGK, CCND2, TCL1A | More | | Adenosine-phosphate | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Adenosine-phosphate | hsa04213 | Longevity regulating pathway - multiple species | 4.79E-02 | 2 | Q08828, P0DMV8 | ADCY1, HSPA1A | More | | Adenosine-phosphate | hsa04216 | Ferroptosis | 1.52E-02 | 1 | Q9UKU0 | ACSL6 | More | | Adenosine-phosphate | hsa04217 | Necroptosis | 1.18E-06 | 17 | P01375, P23458, P48023, Q9NQC7, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, Q99878, Q13557, Q9H444, O75351, P21796, P45880 | TNF, JAK1, FASLG, CYLD, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AC14, CAMK2D, CHMP4B, VPS4B, VDAC1, VDAC2 | More | | Adenosine-phosphate | hsa04261 | Adrenergic signaling in cardiomyocytes | 7.00E-04 | 7 | P07550, P51828, P22694, Q99941, P18848, Q13362, Q13557 | ADRB2, ADCY7, PRKACB, CREBL1, ATF4, PPP2R5C, CAMK2D | More | | Adenosine-phosphate | hsa04270 | Vascular smooth muscle contraction | 1.47E-03 | 4 | P0DP23, Q08828, P35579, P35318 | CALM1, ADCY1, MYH9, ADM | More | | Adenosine-phosphate | hsa04310 | Wnt signaling pathway | 2.28E-04 | 5 | P30279, Q13485, O43318, P17612, P67870 | CCND2, SMAD4, MAP3K7, PRKACA, CSNK2B | More | | Adenosine-phosphate | hsa04330 | Notch signaling pathway | 3.28E-03 | 4 | Q92542, P49768, Q92830, P78504 | NCSTN, PSEN1, KAT2A, JAG1 | More | | Adenosine-phosphate | hsa04340 | Hedgehog signaling pathway | 3.91E-02 | 1 | P17612 | PRKACA | More | | Adenosine-phosphate | hsa04360 | Axon guidance | 2.19E-02 | 3 | P42338, O14639, P24844 | PIK3CB, ABLIM1, MYL9 | More | | Adenosine-phosphate | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Adenosine-phosphate | hsa04510 | Focal adhesion | 4.60E-02 | 3 | Q15942, P51636, P30281 | ZYX, CAV2, CCND3 | More | | Adenosine-phosphate | hsa04520 | Adherens junction | 3.91E-02 | 2 | Q13485, O43318 | SMAD4, MAP3K7 | More | | Adenosine-phosphate | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.16E-02 | 2 | P04628, P40189 | WNT1, IL6ST | More | | Adenosine-phosphate | hsa04610 | Complement and coagulation cascades | 4.31E-07 | 4 | P00734, P0C0L4, P05107, P21730 | F2, C4A, ITGB2, C5AR1 | More | | Adenosine-phosphate | hsa04611 | Platelet activation | 2.12E-02 | 2 | Q9Y490, P17612 | TLN1, PRKACA | More | | Adenosine-phosphate | hsa04612 | Antigen processing and presentation | 7.59E-04 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Adenosine-phosphate | hsa04613 | Neutrophil extracellular trap formation | 3.66E-05 | 16 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Adenosine-phosphate | hsa04620 | Toll-like receptor signaling pathway | 2.22E-04 | 3 | P01584, P45985, Q8NHW4 | IL1B, MAP2K4, CCL4L2 | More | | Adenosine-phosphate | hsa04621 | NOD-like receptor signaling pathway | 1.90E-03 | 8 | P01584, P07900, P25963, P43490, Q05823, P01375, P49913, P12838 | IL1B, HSP90AA1, NFKBIA, PBEF1, RNASEL, TNF, CAMP, DEFA4 | More | | Adenosine-phosphate | hsa04622 | RIG-I-like receptor signaling pathway | 1.36E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Adenosine-phosphate | hsa04623 | Cytosolic DNA-sensing pathway | 6.29E-06 | 3 | P01584, Q9Y535, Q8NHW4 | IL1B, POLR3H, CCL4L2 | More | | Adenosine-phosphate | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Adenosine-phosphate | hsa04630 | JAK-STAT signaling pathway | 3.09E-03 | 3 | O75925, P40189, Q06124 | PIAS1, IL6ST, PTPN11 | More | | Adenosine-phosphate | hsa04640 | Hematopoietic cell lineage | 4.95E-02 | 3 | P01730, P06127, P09564 | CD4, CD5, CD7 | More | | Adenosine-phosphate | hsa04650 | Natural killer cell mediated cytotoxicity | 4.34E-03 | 8 | P01375, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Adenosine-phosphate | hsa04657 | IL-17 signaling pathway | 3.41E-06 | 10 | P07900, O00463, Q16539, P49841, P09341, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, LCN2, TNF, IL1B | More | | Adenosine-phosphate | hsa04658 | Th1 and Th2 cell differentiation | 1.75E-05 | 12 | Q04759, P07766, P20963, Q16539, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, MAPK14, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Adenosine-phosphate | hsa04659 | Th17 cell differentiation | 1.01E-06 | 16 | Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P14778, Q9HBE5, Q9UL17, Q13485, P07900, P08238, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, IL1R1, IL21R, TBX21, SMAD4, HSP90AA1, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.736 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.936 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.754 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.831 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.703 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.768 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.876 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.748 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.816 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.733 |
| Adenosine-phosphate | hsa04660 | T cell receptor signaling pathway | 2.11E-06 | 14 | P01375, Q04759, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Adenosine-phosphate | hsa04662 | B cell receptor signaling pathway | 1.12E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Adenosine-phosphate | hsa04664 | Fc epsilon RI signaling pathway | 3.92E-05 | 6 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Adenosine-phosphate | hsa04666 | Fc gamma R-mediated phagocytosis | 2.66E-02 | 5 | O75015, P06396, O14494, Q9UQC2, P17252 | FCGR3B, GSN, PLPP1, GAB2, PRKCA | More | | Adenosine-phosphate | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Adenosine-phosphate | hsa04710 | Circadian rhythm | 4.40E-02 | 1 | O15516 | CLOCK | More | | Adenosine-phosphate | hsa04713 | Circadian entrainment | 4.76E-02 | 4 | P0DP23, Q13557, P62873, P63218 | CALM1, CAMK2D, GNB1, GNG5 | More | | Adenosine-phosphate | hsa04714 | Thermogenesis | 8.35E-03 | 5 | P51828, P62753, Q9UKU0, P12074, O15239 | ADCY7, RPS6, ACSL6, COX6A1, NDUFA1 | More | | Adenosine-phosphate | hsa04721 | Synaptic vesicle cycle | 3.77E-02 | 1 | P43003 | SLC1A3 | More | | Adenosine-phosphate | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Adenosine-phosphate | hsa04724 | Glutamatergic synapse | 3.88E-04 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Adenosine-phosphate | hsa04725 | Cholinergic synapse | 4.15E-04 | 7 | P51828, P62873, P63218, P50151, P18848, Q13557, P42338 | ADCY7, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB | More | | Adenosine-phosphate | hsa04727 | GABAergic synapse | 3.26E-05 | 5 | P62873, P63218, P50151, P15104, P46459 | GNB1, GNG5, GNG10, GLUL, NSF | More | | Adenosine-phosphate | hsa04728 | Dopaminergic synapse | 3.11E-04 | 11 | P62873, P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407, P0DP23, P48058 | GNB1, GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, CALM1, GRIA4 | More | | Adenosine-phosphate | hsa04740 | Olfactory transduction | 9.79E-03 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Adenosine-phosphate | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Adenosine-phosphate | hsa04744 | Phototransduction | 1.42E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Adenosine-phosphate | hsa04750 | Inflammatory mediator regulation of TRP channels | 6.12E-04 | 7 | P01584, Q08828, Q13557, P19174, P24723, P0DP23, P01042 | IL1B, ADCY1, CAMK2D, PLCG1, PRKCH, CALM1, KNG1 | More | | Adenosine-phosphate | hsa04911 | Insulin secretion | 5.39E-05 | 5 | P51828, P22694, Q99941, P18848, Q13557 | ADCY7, PRKACB, CREBL1, ATF4, CAMK2D | More | | Adenosine-phosphate | hsa04912 | GnRH signaling pathway | 5.60E-04 | 9 | P17252, Q08828, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP23 | PRKCA, ADCY1, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM1 | More | | Adenosine-phosphate | hsa04913 | Ovarian steroidogenesis | 2.52E-02 | 1 | P06213 | INSR | More | | Adenosine-phosphate | hsa04915 | Estrogen signaling pathway | 1.13E-07 | 10 | Q99941, P18848, Q08828, P51828, P07900, P08238, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSP90AB1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Adenosine-phosphate | hsa04916 | Melanogenesis | 3.82E-02 | 3 | Q13557, P0DP23, Q08828 | CAMK2D, CALM1, ADCY1 | More | | Adenosine-phosphate | hsa04918 | Thyroid hormone synthesis | 1.94E-04 | 5 | P22694, P51828, Q99941, P18848, P02768 | PRKACB, ADCY7, CREBL1, ATF4, ALB | More | | Adenosine-phosphate | hsa04920 | Adipocytokine signaling pathway | 1.88E-04 | 3 | Q06124, Q9UKU0, Q9Y478 | PTPN11, ACSL6, PRKAB1 | More | | Adenosine-phosphate | hsa04921 | Oxytocin signaling pathway | 4.38E-02 | 4 | P0DP23, Q08828, Q13557, Q96RR4 | CALM1, ADCY1, CAMK2D, CAMKK2 | More | | Adenosine-phosphate | hsa04923 | Regulation of lipolysis in adipocytes | 5.74E-03 | 3 | P22694, P07550, P06213 | PRKACB, ADRB2, INSR | More | | Adenosine-phosphate | hsa04924 | Renin secretion | 1.45E-04 | 4 | P22694, P07550, Q14643, P0DP23 | PRKACB, ADRB2, ITPR1, CALM1 | More | | Adenosine-phosphate | hsa04925 | Aldosterone synthesis and secretion | 3.47E-04 | 5 | Q99941, P18848, P51828, P0DP23, Q13557 | CREBL1, ATF4, ADCY7, CALM1, CAMK2D | More | | Adenosine-phosphate | hsa04926 | Relaxin signaling pathway | 5.84E-06 | 9 | P42338, P63218, P50151, Q99941, P18848, P49767, P51828, P30679, P49407 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7, GNA15, ARRB1 | More | | Adenosine-phosphate | hsa04927 | Cortisol synthesis and secretion | 1.73E-04 | 4 | Q99941, P18848, P51828, P22694 | CREBL1, ATF4, ADCY7, PRKACB | More | | Adenosine-phosphate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Adenosine-phosphate | hsa04929 | GnRH secretion | 1.54E-03 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Adenosine-phosphate | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Adenosine-phosphate | hsa04931 | Insulin resistance | 1.48E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Adenosine-phosphate | hsa04932 | Non-alcoholic fatty liver disease | 2.27E-05 | 9 | P01375, P49841, O43521, P48023, O75460, P01584, P12074, O15239, O95298 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX6A1, NDUFA1, NDUFC2 | More | | Adenosine-phosphate | hsa04934 | Cushing syndrome | 1.15E-04 | 6 | Q99941, P18848, P51828, P22694, Q13557, P46527 | CREBL1, ATF4, ADCY7, PRKACB, CAMK2D, CDKN1B | More | | Adenosine-phosphate | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Adenosine-phosphate | hsa04940 | Type I diabetes mellitus | 5.08E-05 | 4 | P10747, P48023, P13765, P01375 | CD28, FASLG, HLA-DOB, TNF | More | | Adenosine-phosphate | hsa04950 | Maturity onset diabetes of the young | 8.73E-04 | 1 | P35557 | GCK | More | | Adenosine-phosphate | hsa04960 | Aldosterone-regulated sodium reabsorption | 7.59E-03 | 2 | O00141, P06213 | SGK, INSR | More | | Adenosine-phosphate | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Adenosine-phosphate | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Adenosine-phosphate | hsa04970 | Salivary secretion | 2.76E-05 | 6 | P07550, Q08828, P22694, Q14643, P0DP23, P49913 | ADRB2, ADCY1, PRKACB, ITPR1, CALM1, CAMP | More | | Adenosine-phosphate | hsa04971 | Gastric acid secretion | 1.74E-03 | 5 | Q08828, P51828, P15311, P0DP23, Q13557 | ADCY1, ADCY7, VIL2, CALM1, CAMK2D | More | | Adenosine-phosphate | hsa04979 | Cholesterol metabolism | 6.61E-03 | 3 | Q5SW96, P38571, P61916 | LDLRAP1, LIPA, NPC2 | More | | Adenosine-phosphate | hsa05010 | Alzheimer disease | 4.33E-03 | 16 | O15239, O95298, P19404, P05496, P13073, P12074, Q00535, O75460, P0DP23, P01584, P18848, Q71U36, Q13509, P05141, P21796, P45880 | NDUFA1, NDUFC2, NDUFV2, ATP5G1, COX4I1, COX6A1, CDK5, ERN1, CALM1, IL1B, ATF4, TUBA1A, TUBB3, SLC25A5, VDAC1, VDAC2 | More | | Adenosine-phosphate | hsa05012 | Parkinson disease | 1.47E-05 | 17 | P62987, O15239, O95298, P19404, P13073, P12074, P05496, P05141, P21796, P45880, O75460, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509 | UBA52, NDUFA1, NDUFC2, NDUFV2, COX4I1, COX6A1, ATP5G1, SLC25A5, VDAC1, VDAC2, ERN1, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Adenosine-phosphate | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Adenosine-phosphate | hsa05016 | Huntington disease | 1.16E-03 | 16 | O15239, O95298, P19404, P13073, P12074, P05496, Q13547, P24928, P30876, P62487, P05141, P21796, P45880, O75460, Q71U36, Q13509 | NDUFA1, NDUFC2, NDUFV2, COX4I1, COX6A1, ATP5G1, HDAC1, POLR2A, POLR2B, POLR2G, SLC25A5, VDAC1, VDAC2, ERN1, TUBA1A, TUBB3 | More | | Adenosine-phosphate | hsa05017 | Spinocerebellar ataxia | 1.93E-03 | 5 | Q92915, Q8TB72, O15399, P42338, P21796 | FGF14, PUM2, GRIN2D, PIK3CB, VDAC1 | More | | Adenosine-phosphate | hsa05020 | Prion disease | 9.64E-03 | 10 | P11142, P19404, P13073, P18848, P05141, P21796, P45880, Q71U36, Q13509, Q99941 | HSPA8, NDUFV2, COX4I1, ATF4, SLC25A5, VDAC1, VDAC2, TUBA1A, TUBB3, CREBL1 | More | | Adenosine-phosphate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.68E-04 | 21 | Q71U36, Q13509, O15239, O95298, P19404, P13073, P12074, P05496, Q8TEV9, P21796, O75460, P18848, P19174, P05141, P45880, P20333, Q00535, P01584, P0DP23, Q13557, P62987 | TUBA1A, TUBB3, NDUFA1, NDUFC2, NDUFV2, COX4I1, COX6A1, ATP5G1, SMCR8, VDAC1, ERN1, ATF4, PLCG1, SLC25A5, VDAC2, TNFRSF1B, CDK5, IL1B, CALM1, CAMK2D, UBA52 | More | | Adenosine-phosphate | hsa05030 | Cocaine addiction | 4.44E-03 | 3 | P22694, Q99941, P18848 | PRKACB, CREBL1, ATF4 | More | | Adenosine-phosphate | hsa05031 | Amphetamine addiction | 1.49E-04 | 5 | P0DP23, Q13557, Q99941, P18848, Q13547 | CALM1, CAMK2D, CREBL1, ATF4, HDAC1 | More | | Adenosine-phosphate | hsa05034 | Alcoholism | 1.27E-02 | 7 | Q99941, P18848, Q13547, P0DP23, P62873, P63218, O60814 | CREBL1, ATF4, HDAC1, CALM1, GNB1, GNG5, H2BC12 | More | | Adenosine-phosphate | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Adenosine-phosphate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 5.36E-05 | 6 | Q16539, Q99437, P09341, P25024, P25025, P41240 | MAPK14, ATP6V0B, CXCL1, CXCR1, CXCR2, CSK | More | | Adenosine-phosphate | hsa05133 | Pertussis | 8.35E-05 | 3 | P05107, P10145, P0C0L4 | ITGB2, IL8, C4A | More | | Adenosine-phosphate | hsa05134 | Legionellosis | 3.35E-02 | 4 | P11215, P68104, P11142, P19875 | ITGAM, EEF1A1, HSPA8, CXCL2 | More | | Adenosine-phosphate | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | | Adenosine-phosphate | hsa05143 | African trypanosomiasis | 4.74E-05 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Adenosine-phosphate | hsa05144 | Malaria | 1.48E-05 | 5 | P69905, P68871, O60603, P05107, P10145 | HBA2, HBB, TLR2, ITGB2, IL8 | More | | Adenosine-phosphate | hsa05146 | Amoebiasis | 1.25E-04 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | | Adenosine-phosphate | hsa05150 | Staphylococcus aureus infection | 1.33E-06 | 12 | P0C0L4, P21730, P21462, O75015, P13765, P13646, Q14532, P05107, P59665, P59666, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, HLA-DOB, KRT13, KRT32, ITGB2, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Adenosine-phosphate | hsa05152 | Tuberculosis | 1.95E-02 | 5 | P48382, P10415, P13765, Q9UDY8, P51617 | RFX5, BCL2, HLA-DOB, MALT1, IRAK1 | More | | Adenosine-phosphate | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Adenosine-phosphate | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Adenosine-phosphate | hsa05162 | Measles | 8.38E-03 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Adenosine-phosphate | hsa05163 | Human cytomegalovirus infection | 1.27E-05 | 15 | P01375, P50151, Q14643, P0DP23, Q8NHW4, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P04637, O00463 | TNF, GNG10, ITPR1, CALM1, CCL4L2, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, TP53, TRAF5 | More | | Adenosine-phosphate | hsa05165 | Human papillomavirus infection | 9.48E-04 | 8 | P46527, P35443, P01375, Q08999, Q9UM47, P22694, Q13362, Q13315 | CDKN1B, THBS4, TNF, RBL2, NOTCH3, PRKACB, PPP2R5C, ATM | More | | Adenosine-phosphate | hsa05166 | Human T-cell leukemia virus 1 infection | 4.93E-02 | 6 | P22694, P18848, P25963, P25208, Q13315, P01375 | PRKACB, ATF4, NFKBIA, NFYB, ATM, TNF | More | | Adenosine-phosphate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 7 | P42224, P62873, P63218, P19875, P19174, P07948, P0DP23 | STAT1, GNB1, GNG5, CXCL2, PLCG1, LYN, CALM1 | More | | Adenosine-phosphate | hsa05169 | Epstein-Barr virus infection | 4.48E-03 | 9 | Q13547, P42338, P07948, P30101, Q13761, O75293, P30279, P42224, P07766 | HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CCND2, STAT1, CD3E | More | | Adenosine-phosphate | hsa05171 | Coronavirus disease - COVID-19 | 3.18E-03 | 7 | P01584, P62753, P36578, P62888, P61927, P61513, P62829 | IL1B, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23 | More | | Adenosine-phosphate | hsa05200 | Pathways in cancer | 1.83E-04 | 19 | Q16363, P07900, P08238, P42224, P19174, P43246, Q13485, P20585, P52701, Q13547, P30279, P62873, P63218, P78417, O75293, P0DP23, Q13557, P14784, P01042 | LAMA4, HSP90AA1, HSP90AB1, STAT1, PLCG1, MSH2, SMAD4, MSH3, MSH6, HDAC1, CCND2, GNB1, GNG5, GSTO1, GADD45B, CALM1, CAMK2D, IL2RB, KNG1 | More | | Adenosine-phosphate | hsa05202 | Transcriptional misregulation in cancer | 2.64E-10 | 24 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P46527, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P68431, Q92769, P12980, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, CDKN1B, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q12778 | FOXO1 | Forkhead box protein O1 | 0.716 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | Q15532 | SS18 | Protein SSXT | -0.84 | P21589 | NT5E | 5'-nucleotidase | Q15532 | SS18 | Protein SSXT | 0.77 | P22748 | CA4 | Carbonic anhydrase 4 | Q15532 | SS18 | Protein SSXT | -0.862 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q13315 | ATM | Serine-protein kinase ATM | 0.858 | P49913 | CAMP | Cathelicidin antimicrobial peptide | Q13315 | ATM | Serine-protein kinase ATM | -0.775 | P22748 | CA4 | Carbonic anhydrase 4 | P41732 | TSPAN7 | Tetraspanin-7 | 0.706 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P41732 | TSPAN7 | Tetraspanin-7 | -0.733 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.861 | P22748 | CA4 | Carbonic anhydrase 4 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.925 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.74 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.826 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.778 | P22748 | CA4 | Carbonic anhydrase 4 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.708 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.701 | P04183 | TK1 | Thymidine kinase, cytosolic | P14923 | JUP | Junction plakoglobin | -0.774 | P21589 | NT5E | 5'-nucleotidase | P14923 | JUP | Junction plakoglobin | 0.87 | P22748 | CA4 | Carbonic anhydrase 4 | P14923 | JUP | Junction plakoglobin | -0.772 | P04183 | TK1 | Thymidine kinase, cytosolic | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.781 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.779 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.933 | P22748 | CA4 | Carbonic anhydrase 4 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.833 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.742 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.769 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.774 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.832 | P22748 | CA4 | Carbonic anhydrase 4 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.718 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.788 | P21589 | NT5E | 5'-nucleotidase | O15550 | UTX | Lysine-specific demethylase 6A | -0.78 | P22748 | CA4 | Carbonic anhydrase 4 | O15550 | UTX | Lysine-specific demethylase 6A | 0.714 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P46527 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | -0.8 | P21589 | NT5E | 5'-nucleotidase | P04637 | TP53 | Cellular tumor antigen p53 | 0.701 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.802 | P22748 | CA4 | Carbonic anhydrase 4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.834 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.759 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.723 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.802 | P22748 | CA4 | Carbonic anhydrase 4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.834 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.759 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.723 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P05164 | MPO | Myeloperoxidase | 0.7 | P04183 | TK1 | Thymidine kinase, cytosolic | P05164 | MPO | Myeloperoxidase | 0.917 | P21589 | NT5E | 5'-nucleotidase | P05164 | MPO | Myeloperoxidase | -0.706 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P05164 | MPO | Myeloperoxidase | -0.817 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P12838 | DEFA4 | Neutrophil defensin 4 | -0.719 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P12838 | DEFA4 | Neutrophil defensin 4 | -0.796 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P12838 | DEFA4 | Neutrophil defensin 4 | 0.718 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P08246 | ELA2 | Neutrophil elastase | 0.768 | P04183 | TK1 | Thymidine kinase, cytosolic | P08246 | ELA2 | Neutrophil elastase | 0.838 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | P08246 | ELA2 | Neutrophil elastase | -0.772 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P08246 | ELA2 | Neutrophil elastase | 0.807 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.729 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.807 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.776 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | -0.757 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q92769 | HDAC2 | Histone deacetylase 2 | 0.735 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P12980 | LYL1 | Protein lyl-1 | -0.709 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.712 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | P22748 | CA4 | Carbonic anhydrase 4 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.769 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.737 |
| Adenosine-phosphate | hsa05203 | Viral carcinogenesis | 5.01E-06 | 16 | Q08999, Q99941, P18848, P06746, P07948, P30279, P27348, P29083, Q7KZF4, P46527, Q13547, P06396, P25963, P61978, P22694, O60814 | RBL2, CREBL1, ATF4, POLB, LYN, CCND2, YWHAQ, GTF2E1, SND1, CDKN1B, HDAC1, GSN, NFKBIA, HNRPK, PRKACB, H2BC12 | More | | Adenosine-phosphate | hsa05206 | MicroRNAs in cancer | 1.67E-02 | 4 | P46527, Q9UM47, P35226, Q13315 | CDKN1B, NOTCH3, BMI1, ATM | More | | Adenosine-phosphate | hsa05210 | Colorectal cancer | 4.94E-02 | 2 | Q13485, P52701 | SMAD4, MSH6 | More | | Adenosine-phosphate | hsa05214 | Glioma | 1.76E-02 | 4 | P0DP23, Q13557, P19174, O75293 | CALM1, CAMK2D, PLCG1, GADD45B | More | | Adenosine-phosphate | hsa05217 | Basal cell carcinoma | 3.30E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Adenosine-phosphate | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Adenosine-phosphate | hsa05221 | Acute myeloid leukemia | 3.29E-02 | 3 | P14923, Q15744, P05164 | JUP, CEBPE, MPO | More | | Adenosine-phosphate | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Adenosine-phosphate | hsa05226 | Gastric cancer | 2.94E-02 | 2 | P04628, P10826 | WNT1, RARB | More | | Adenosine-phosphate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.48E-05 | 9 | O95267, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Adenosine-phosphate | hsa05310 | Asthma | 4.06E-04 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Adenosine-phosphate | hsa05321 | Inflammatory bowel disease | 2.56E-04 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Adenosine-phosphate | hsa05322 | Systemic lupus erythematosus | 4.51E-02 | 6 | O75015, P08246, P08311, P01375, P10747, P13765 | FCGR3B, ELA2, CTSG, TNF, CD28, HLA-DOB | More | | Adenosine-phosphate | hsa05323 | Rheumatoid arthritis | 2.62E-02 | 4 | P01375, P13765, P10747, P09341 | TNF, HLA-DOB, CD28, CXCL1 | More | | Adenosine-phosphate | hsa05330 | Allograft rejection | 2.06E-04 | 4 | P13765, P48023, P10747, P01375 | HLA-DOB, FASLG, CD28, TNF | More | | Adenosine-phosphate | hsa05332 | Graft-versus-host disease | 5.75E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Adenosine-phosphate | hsa05410 | Hypertrophic cardiomyopathy | 2.60E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Adenosine-phosphate | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Adenosine-phosphate | hsa05415 | Diabetic cardiomyopathy | 5.24E-03 | 12 | P17252, Q15080, O15239, Q16718, O95298, O14521, P05496, P12074, Q16539, P49841, Q13557, P14780 | PRKCA, NCF4, NDUFA1, NDUFA5, NDUFC2, SDHD, ATP5G1, COX6A1, MAPK14, GSK3B, CAMK2D, MMP9 | More | | Adenosine-phosphate | hsa05418 | Fluid shear stress and atherosclerosis | 1.26E-04 | 8 | Q16539, Q14145, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |